J Rheumatol
-
Clinical Trial
Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.
Rheumatoid arthritis (RA) is associated with increased risk for cardiovascular (CV) events through multiple factors. Fish oil has been shown to reduce symptoms in RA and to reduce CV risk. We assessed the effect of an antiinflammatory dose of fish oil on CV risk factors within a program of combination chemotherapy for patients with early RA. ⋯ Fish oil reduces cardiovascular risk in patients with RA through multiple mechanisms.
-
Administrative data bases provide rapid access to data regarding treatment and morbidity of rheumatoid arthritis (RA). A serious limitation of administrative data bases is the lack of information regarding RA severity, as in the case of lymphoma, where RA severity may contribute to the cause of the adverse outcome. We examined whether treatment variables could predict RA severity. ⋯ Treatment variables do not accurately or usefully identify severity status. As a corollary, there is little difference in severity between patients receiving different treatment regimens, and actual measures of severity rather than treatment surrogates are required to assess RA severity.
-
Editorial Comment
Collateral benefits of fish oil therapy for rheumatoid arthritis.
-
Controlled Clinical Trial
Sleep quality in patients with fibromyalgia using the Pittsburgh Sleep Quality Index.
To characterize and quantify the sleep complaints of patients with fibromyalgia (FM) using the Pittsburgh Sleep Quality Index (PSQI). ⋯ Our results indicate that the PSQI is a useful instrument for characterizing and quantifying sleep disturbances in patients with FM.